Corton Capital Inc. Organon & Co. Transaction History

Corton Capital Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $66,750 - $91,067	4,844 Added 15.32%	36,467 $685,000
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $231,515 - $366,196	21,143 Added 201.75%	31,623 $456,000
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $173,863 - $249,109	10,480 New	10,480 $181,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $235,867 - $289,805	-7,450 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $226,852 - $293,232	7,450 New	7,450 $260,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.